Not Tagged
Not Tagged
['breast']
today at #asco23 one of our research partners will present a study showing plasma-based genotyping with guardant360 can detect esr1 mutations that qualify patients with metastatic #breastcancer to receive fda-approved serd therapy, including repeat testing over time. 
We're a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets and advanced analytics.